Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001566575 | SCV001790117 | likely pathogenic | not provided | 2024-02-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); Observed in an individual with severe aplastic anemia (PMID: 35776903); This variant is associated with the following publications: (PMID: 35776903) |
Prevention |
RCV004536195 | SCV004710869 | likely pathogenic | FANCM-related disorder | 2023-12-28 | no assertion criteria provided | clinical testing | The FANCM c.5047A>T variant is predicted to result in premature protein termination (p.Lys1683*). This variant has been reported in an individual with Aplastic anemia (McReynolds et al. 2022. PubMed ID: 35776903. Table S2A). This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in FANCM are expected to be pathogenic. This variant is interpreted as likely pathogenic. |